VETRO, CALOGERO
VETRO, CALOGERO
Università degli Studi di CATANIA
A case of high-risk AML in a patient with advanced systemic mastocytosis
2023-01-01 Fazio, Manlio; Vetro, Calogero; Markovic, Uroš; Duminuco, Andrea; Parisi, Marina; Maugeri, Cinzia; Mauro, Elisa; Parrinello, Nunziatina Laura; Stagno, Fabio; Villari, Loredana; Triolo, Anna Maria; Stella, Stefania; Palumbo, Giuseppe A; Di Raimondo, Francesco; Romano, Alessandra; Zanotti, Roberta
Abnormal F-18 fluorodeoxyglucose uptake of the lung in immunocompromised lymphoma patients in complete remission: Report of two cases and revision of literature
2013-01-01 Conticello, C.; Vetro, C.; Romano, A.; Amato, G.; Schinocca, L.; Cosentino, S.; Ippolito, M.; Giustolisi, R.; Di Raimondo, F.
Advances in understanding regulatory myeloid cells
file da validare2011-01-01 Romano, A.; Vetro, C.; Adriani, M.
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells
2015-01-01 Martelli, Mp; Gionfriddo, I; Mezzasoma, F; Milano, F; Pierangeli, S; Mulas, F; Pacini, R; Tabarrini, A.; Pettirossi, V; Rossi, R; Vetro, C; Brunetti, L; Sportoletti, P; Tiacci, E; Di Raimondo, F; Falini, B
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders
file da validare2026-01-01 Duminuco, Andrea; De Luca, Paola; Stanzione, Gaia; Caruso, Laura Anastasia; Lavenia, Giulio; Scarso, Salvatore; Garibaldi, Bruno; Palumbo, Fanny Erika; Vetro, Calogero; Palumbo, Giuseppe Alberto
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells
2015-01-01 Vetro, C; Romano, A; Ancora, Flavia; Coppolino, F; Brundo, M. V.; Raccuia, Sa; Puglisi, F; Tibullo, D; La Cava, P; Giallongo, C; Parrinello, Nl
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells
2021-01-01 Massimino, M.; Vigneri, P.; Stella, S.; Tirro, E.; Pennisi, M. S.; Parrinello, L. N.; Vetro, C.; Manzella, L.; Stagno, F.; Di Raimondo, F.
Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational Study
file da validare2025-01-01 Longo, E.; Palumbo, F. E.; Duminuco, A.; Longo, L.; Vitale, D. C.; Brancati, S.; Maugeri, C.; Parisi, M. S.; Palumbo, G. A.; Romano, G. L.; Drago, F.; Di Raimondo, F.; Gozzo, L.; Vetro, C.
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease
2024-01-01 Gozzo, Lucia; Leotta, Salvatore; Romano, Giovanni Luca; Vetro, Calogero; Duminuco, Andrea; Milone, Giuseppe; Cupri, Alessandra; Erika Palumbo, Fanny; Brancati, Serena; Ruscica, Rosy; Longo, Laura; Vitale, Daniela Cristina; Fiorenza, Giorgia; Enrico Lombardo, Giovanni; Lazzara, Antonio; Di Raimondo, Francesco; Palumbo, Giuseppe Alberto Maria; Drago, Filippo
Emerging Therapeutic Approaches for Anemia in Myelofibrosis
2025-01-01 Chifotides, Helen T.; Duminuco, Andrea; Torre, Elena; Vetro, Calogero; Harrington, Patrick; Palumbo, Giuseppe A.; Bose, Prithviraj
Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up
2014-01-01 Vetro, C.; Romano, A.; Amico, I.; Conticello, C.; Motta, G.; Figuera, A.; Chiarenza, A.; Di Raimondo, C.; Giulietti, G.; Bonanno, G.; Palumbo, G. A.; Di Raimondo, F.
Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters
2021-01-01 Duminuco, Andrea; Palumbo, Giuseppe; Garibaldi, Bruno; Foti, Rosario; Di Raimondo, Francesco; Maugeri, Cinzia; Mauro, Elisa; Fiumara, Paolo; Vetro, Calogero
Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model
file da validare2026-01-01 Duminuco, Andrea; Vitale, Silvia Rita; Nardo, Antonella; Harrington, Patrick; Stella, Stefania; Massimino, Michele; Tomarchio, Cristina; Mauro, Elisa; Parisi, Marina S; Maugeri, Cinzia; Di Raimondo, Francesco; Palumbo, Giuseppe A; Manzella, Livia; Vetro, Calogero
Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax
file da validare2025-01-01 Palumbo, F. E.; Duminuco, A.; Longo, L.; Vitale, D. C.; Maugeri, C.; Brancati, S.; Parisi, M. S.; Palumbo, G. A.; Romano, G. L.; Drago, F.; Di Raimondo, F.; Gozzo, L.; Vetro, C.
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database
2021-01-01 Gozzo, L.; Vetro, C.; Brancati, S.; Longo, L.; Vitale, D. C.; Romano, G. L.; Mauro, E.; Fiumara, P. F.; Maugeri, C.; Parisi, M. S.; Dulcamare, I.; Garibaldi, B.; Duminuco, A.; Palumbo, G. A.; Di Raimondo, F.; Drago, F.
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape
file da validare2025-01-01 Duminuco, A.; Harrington, P.; Del Fabro, V.; Scalisi, E.; Santuccio, G.; Santisi, A.; Sbriglione, A.; Garibaldi, B.; Markovic, U.; Di Raimondo, F.; Palumbo, G. A.; Pugliese, N.; Vetro, C.
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance
2022-01-01 Vetro, Calogero; Duminuco, Andrea; Gozzo, Lucia; Maugeri, Cinzia; Parisi, Marina; Brancati, Serena; Longo, Laura; Vitale, Daniela Cristina; Romano, Giovanni Luca; Ciuni, Roberto; Mauro, Elisa; Fiumara, Paolo Fabio; Palumbo, Giuseppe Alberto Maria; Drago, Filippo; Raimondo, Francesco Di
Pegylated liposomal doxorubicin in salvage chemotherapy for multiple myeloma patients
file da validare2013-01-01 Romano, Alessandra; Uccello, Giuseppina; Spina, Paolo; Cunsolo, Rosario; Vetro, Calogero; Di Raimondo, Francesco
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting
2022-01-01 Duminuco, Andrea; Nardo, Antonella; Garibaldi, Bruno; Vetro, Calogero; Longo, Anna; Giallongo, Cesarina; Di Raimondo, Francesco; Palumbo, Giuseppe A
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy
2018-01-01 Romano, Alessandra; Parrinello, Nunziatina Laura; Vetro, Calogero; Chiarenza, Annalisa; Cerchione, Claudio; Ippolito, Massimo; Palumbo, Giuseppe Alberto; Di Raimondo, Francesco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A case of high-risk AML in a patient with advanced systemic mastocytosis | 1-gen-2023 | Fazio, Manlio; Vetro, Calogero; Markovic, Uroš; Duminuco, Andrea; Parisi, Marina; Maugeri, Cinzia; Mauro, Elisa; Parrinello, Nunziatina Laura; Stagno, Fabio; Villari, Loredana; Triolo, Anna Maria; Stella, Stefania; Palumbo, Giuseppe A; Di Raimondo, Francesco; Romano, Alessandra; Zanotti, Roberta | |
| Abnormal F-18 fluorodeoxyglucose uptake of the lung in immunocompromised lymphoma patients in complete remission: Report of two cases and revision of literature | 1-gen-2013 | Conticello, C.; Vetro, C.; Romano, A.; Amato, G.; Schinocca, L.; Cosentino, S.; Ippolito, M.; Giustolisi, R.; Di Raimondo, F. | |
| Advances in understanding regulatory myeloid cells | 1-gen-2011 | Romano, A.; Vetro, C.; Adriani, M. | file da validare |
| Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells | 1-gen-2015 | Martelli, Mp; Gionfriddo, I; Mezzasoma, F; Milano, F; Pierangeli, S; Mulas, F; Pacini, R; Tabarrini, A.; Pettirossi, V; Rossi, R; Vetro, C; Brunetti, L; Sportoletti, P; Tiacci, E; Di Raimondo, F; Falini, B | |
| BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders | 1-gen-2026 | Duminuco, Andrea; De Luca, Paola; Stanzione, Gaia; Caruso, Laura Anastasia; Lavenia, Giulio; Scarso, Salvatore; Garibaldi, Bruno; Palumbo, Fanny Erika; Vetro, Calogero; Palumbo, Giuseppe Alberto | file da validare |
| Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells | 1-gen-2015 | Vetro, C; Romano, A; Ancora, Flavia; Coppolino, F; Brundo, M. V.; Raccuia, Sa; Puglisi, F; Tibullo, D; La Cava, P; Giallongo, C; Parrinello, Nl | |
| Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells | 1-gen-2021 | Massimino, M.; Vigneri, P.; Stella, S.; Tirro, E.; Pennisi, M. S.; Parrinello, L. N.; Vetro, C.; Manzella, L.; Stagno, F.; Di Raimondo, F. | |
| Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational Study | 1-gen-2025 | Longo, E.; Palumbo, F. E.; Duminuco, A.; Longo, L.; Vitale, D. C.; Brancati, S.; Maugeri, C.; Parisi, M. S.; Palumbo, G. A.; Romano, G. L.; Drago, F.; Di Raimondo, F.; Gozzo, L.; Vetro, C. | file da validare |
| Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease | 1-gen-2024 | Gozzo, Lucia; Leotta, Salvatore; Romano, Giovanni Luca; Vetro, Calogero; Duminuco, Andrea; Milone, Giuseppe; Cupri, Alessandra; Erika Palumbo, Fanny; Brancati, Serena; Ruscica, Rosy; Longo, Laura; Vitale, Daniela Cristina; Fiorenza, Giorgia; Enrico Lombardo, Giovanni; Lazzara, Antonio; Di Raimondo, Francesco; Palumbo, Giuseppe Alberto Maria; Drago, Filippo | |
| Emerging Therapeutic Approaches for Anemia in Myelofibrosis | 1-gen-2025 | Chifotides, Helen T.; Duminuco, Andrea; Torre, Elena; Vetro, Calogero; Harrington, Patrick; Palumbo, Giuseppe A.; Bose, Prithviraj | |
| Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up | 1-gen-2014 | Vetro, C.; Romano, A.; Amico, I.; Conticello, C.; Motta, G.; Figuera, A.; Chiarenza, A.; Di Raimondo, C.; Giulietti, G.; Bonanno, G.; Palumbo, G. A.; Di Raimondo, F. | |
| Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters | 1-gen-2021 | Duminuco, Andrea; Palumbo, Giuseppe; Garibaldi, Bruno; Foti, Rosario; Di Raimondo, Francesco; Maugeri, Cinzia; Mauro, Elisa; Fiumara, Paolo; Vetro, Calogero | |
| Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model | 1-gen-2026 | Duminuco, Andrea; Vitale, Silvia Rita; Nardo, Antonella; Harrington, Patrick; Stella, Stefania; Massimino, Michele; Tomarchio, Cristina; Mauro, Elisa; Parisi, Marina S; Maugeri, Cinzia; Di Raimondo, Francesco; Palumbo, Giuseppe A; Manzella, Livia; Vetro, Calogero | file da validare |
| Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax | 1-gen-2025 | Palumbo, F. E.; Duminuco, A.; Longo, L.; Vitale, D. C.; Maugeri, C.; Brancati, S.; Parisi, M. S.; Palumbo, G. A.; Romano, G. L.; Drago, F.; Di Raimondo, F.; Gozzo, L.; Vetro, C. | file da validare |
| Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database | 1-gen-2021 | Gozzo, L.; Vetro, C.; Brancati, S.; Longo, L.; Vitale, D. C.; Romano, G. L.; Mauro, E.; Fiumara, P. F.; Maugeri, C.; Parisi, M. S.; Dulcamare, I.; Garibaldi, B.; Duminuco, A.; Palumbo, G. A.; Di Raimondo, F.; Drago, F. | |
| Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape | 1-gen-2025 | Duminuco, A.; Harrington, P.; Del Fabro, V.; Scalisi, E.; Santuccio, G.; Santisi, A.; Sbriglione, A.; Garibaldi, B.; Markovic, U.; Di Raimondo, F.; Palumbo, G. A.; Pugliese, N.; Vetro, C. | file da validare |
| Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance | 1-gen-2022 | Vetro, Calogero; Duminuco, Andrea; Gozzo, Lucia; Maugeri, Cinzia; Parisi, Marina; Brancati, Serena; Longo, Laura; Vitale, Daniela Cristina; Romano, Giovanni Luca; Ciuni, Roberto; Mauro, Elisa; Fiumara, Paolo Fabio; Palumbo, Giuseppe Alberto Maria; Drago, Filippo; Raimondo, Francesco Di | |
| Pegylated liposomal doxorubicin in salvage chemotherapy for multiple myeloma patients | 1-gen-2013 | Romano, Alessandra; Uccello, Giuseppina; Spina, Paolo; Cunsolo, Rosario; Vetro, Calogero; Di Raimondo, Francesco | file da validare |
| Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting | 1-gen-2022 | Duminuco, Andrea; Nardo, Antonella; Garibaldi, Bruno; Vetro, Calogero; Longo, Anna; Giallongo, Cesarina; Di Raimondo, Francesco; Palumbo, Giuseppe A | |
| Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy | 1-gen-2018 | Romano, Alessandra; Parrinello, Nunziatina Laura; Vetro, Calogero; Chiarenza, Annalisa; Cerchione, Claudio; Ippolito, Massimo; Palumbo, Giuseppe Alberto; Di Raimondo, Francesco |